Neosphere Biotechnologies Gmbh

Neosphere Biotechnologies Gmbh company information, Employees & Contact Information

NEOsphere Biotechnologies integrates world-class mass spectrometry with expert data analysis to systematically build comprehensive pipelines of novel degrader targets. We support our partners' targeted protein degradation (TPD) drug discovery programs across all stages. Our deep proteomic screening platform, which is target- and E3 ligase-agnostic, enables unbiased, high-throughput screening of entire degrader libraries. With unparalleled proteome coverage, sensitivity, precision, and rapid turnaround, we unlock the previously undruggable target space. Our platform characterizes all degrader types, identifying molecules that engage new E3 ligases and emerging TPD mechanisms. We confirm potential degrader targets and modifications through global ubiquitinomics, achieving unprecedented coverage of > 50,000 ubiquitination sites. Our proprietary data analysis suite is designed for interactive and user-friendly exploration of large proteomics datasets, enabling informed decision-making, SAR optimization, target identification, and library expansion.

Company Details

Employees
12
Founded
-
Address
Fraunhoferstrasse 8, Planegg,82152,germany
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
IT Consulting.
HQ
Planegg
Looking for a particular Neosphere Biotechnologies Gmbh employee's phone or email?

Neosphere Biotechnologies Gmbh Questions

News

High-throughput proteomics is identifying molecular glue degraders at scale - Nature

High-throughput proteomics is identifying molecular glue degraders at scale Nature

NEOsphere Biotechnologies closes financing round - Labiotech.eu

NEOsphere Biotechnologies closes financing round Labiotech.eu

NEOsphere Biotechnologies Partners With Kymera Therapeutics for Novel Molecular Glue Target Discovery - Technology Networks

NEOsphere Biotechnologies Partners With Kymera Therapeutics for Novel Molecular Glue Target Discovery Technology Networks

ICR Centre for Protein Degradation and NEOsphere Biotechnologies announce research collaboration to discover new molecular glue degrader therapeutics - The Institute of Cancer Research

ICR Centre for Protein Degradation and NEOsphere Biotechnologies announce research collaboration to discover new molecular glue degrader therapeutics The Institute of Cancer Research

Neosphere Biotechnologies and Kymera Therapeutics partner to advance molecular glue target discovery - BioWorld MedTech

Neosphere Biotechnologies and Kymera Therapeutics partner to advance molecular glue target discovery BioWorld MedTech

Top Neosphere Biotechnologies Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant